GLABF (Gemina Laboratories) EBITDA Margin %: 0.00% (As of Oct. 2025)


What is Gemina Laboratories EBITDA Margin %?

Gemina Laboratories GLABF -27.59% EBITDA Margin % is 0.00% as of Oct. 2025. The stock has 2 warning signs investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Gemina Laboratories's EBITDA for the three months ended in Oct. 2025 was $-0.24 Mil. Gemina Laboratories's Revenue for the three months ended in Oct. 2025 was $0.00 Mil. Therefore, Gemina Laboratories's EBITDA margin for the quarter that ended in Oct. 2025 was 0.00%.

Gemina Laboratories  (OTCPK:GLABF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Gemina Laboratories EBITDA Margin % Related Terms

Gemina Laboratories EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories EBITDA Margin % Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
EBITDA Margin %
0.00 0.00 0.00 0.00 0.00

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -6,187.50 0.00 0.00

GLABF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Gemina Laboratories's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's EBITDA Margin % falls into.


Gemina Laboratories EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Gemina Laboratories's EBITDA Margin % for the fiscal year that ended in Jan. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2025 )/Revenue (A: Jan. 2025 )
=-2.638/0
= %

Gemina Laboratories's EBITDA Margin % for the quarter that ended in Oct. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Oct. 2025 )/Revenue (Q: Oct. 2025 )
=-0.237/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Gemina Laboratories (GLABF) has a EBITDA Margin % of 0.00% as of Oct. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' EBITDA Margin % too high?
Gemina Laboratories' current EBITDA Margin % is 0.00%.
How does Gemina Laboratories' EBITDA Margin % compare to VRTX and REGN?
Gemina Laboratories' EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current EBITDA Margin % is 0.00% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.